These interesting findings described by Arango-Gonzalez et al. [9] support our results that highlighted the activation of a caspase-independent cell death mechanism in rd10 mouse retinas and point out the promising therapeutic target of modulating the balance of the SIRT1/PARP1 axis in RP. Here, PARP1 is linked to retinitis pigmentosa 1.